Low-value care

Applying the Milan models to setting analytical performance specifications – considering all the information – Graham R.D. Jones et al.

2024-06-04T13:28:01+10:00Clinical quality, Low-value care, Publications, Risk, Tests|

Analytical performance specifications (APS) are used for decisions about the required analytical quality of pathology tests to meet clinical needs. The Milan models, based on clinical outcome, biological variation, or state of the art, were developed to provide a framework for setting APS. An approach [...]

Perceptions and experiences of paramedics managing people with non-traumatic low back pain: a qualitative study of Australian paramedics – Simon P Vella et al.

2024-04-07T13:51:47+10:00Clinical guidelines, Emergency Department, Health literacy, Imaging, Low back pain, Low-value care, Musculoskeletal, Opioids, Pain, Physiotherapy, Publications, Treatment|

Internationally, non-traumatic low back pain (LBP) is an increasingly common presentation to ambulance services. Consequently, paramedics are often the first providers of care for people with LBP. Australian guidelines for paramedic management of LBP recommend the use of simple analgesia, hot/cold therapy and for people [...]

Cutting back on low-value healthcare practices supports sustainable kidney care – Scott McAlister et al.

2024-04-05T15:12:07+11:00Carbon footprint, Carbon neutral, Climate change, Ethical considerations, Kidney, Low-value care, Publications, Shared decision making, Sustainable health care|

July 2023 marked the hottest month on record, underscoring the urgent need for action on climate change. The imperative to reduce carbon emissions extends to all sectors, including health care, with it being responsible for 5.5% of global emissions. In decarbonizing health care, although much [...]

Behavioural ‘nudging’ interventions to reduce low-value care for low back pain in the emergency department (NUDG-ED): protocol for a 2×2 factorial, before-after, cluster randomised trial – Gemma Altinger et al.

2024-04-05T13:06:47+11:00Back pain, Imaging, Low back pain, Low-value care, Musculoskeletal, Opioids, Overuse, Pain, Publications|

Opioids and imaging are considered low-value care for most people with low back pain. Yet around one in three people presenting to the emergency department (ED) will receive imaging, and two in three will receive an opioid. NUDG-ED aims to determine the effectiveness of two [...]

Making recommendations to subsidize new health technologies in Australia: A qualitative study of decision-makers’ perspectives on committee processes – Marcus Sellars et al.

2024-02-13T13:09:26+11:00Decision aids, Low-value care, Publications|

Health technology assessment (HTA) processes and decision making in Australia have significant implications for all Australians, determining what medicines, health technologies and services are subsidized by government. These processes are currently being considered for further reform. Decisions about which medicines, health technologies and services should [...]

How environmental impact is considered in economic evaluations of critical care: a scoping review – Alayna Carrandi et al.

2024-02-11T14:51:20+11:00Carbon footprint, Carbon neutral, Climate change, Low-value care, Publications, Sustainable health care|

Health care is a major contributor to climate change, and critical care is one of the sector’s highest carbon emitters. Health economic evaluations form an important component of critical care and may be useful in identifying economically efficient and environmentally sustainable strategies. The purpose of [...]

Direct-to-consumer tests advertised online in Australia and their implications for medical overuse: systematic online review and a typology of clinical utility – Patti Shih et al.

2024-02-11T14:15:02+11:00Genetic testing, Low-value care, Overdiagnosis, Overtesting, Overtreatment, Overuse, Publications|

The growing number of Direct To Consumer (DTC) tests available for direct purchase online in Australia purport to empower consumers with choice and convenience of access. The categorisation of clinical utility developed in this study shows the majority of currently available products lack clear benefits [...]

The Conversation: You can now order all kinds of medical tests online. Our research shows this is (mostly) a bad idea

2024-02-16T10:48:52+11:00Low-value care, Media, News, Overdiagnosis, Overtesting|

Many of us have done countless rapid antigen tests (RATs) over the course of the pandemic. Testing ourselves at home has become second nature. But there’s also a growing worldwide market in medical tests sold online directly to the public. These are “direct-to-consumer” tests, and [...]

First do no harm in responding to incidental imaging findings – Ian A Scott, John Slavotinek &Paul P Glasziou

2023-12-04T14:34:57+11:00Cancer, Imaging, Low-value care, Overdiagnosis, Overtreatment, Publications, Screening|

You order a computed tomography pulmonary angiogram (CTPA) for a patient with suspected pulmonary thromboembolism. The radiology report states that no pulmonary thromboembolism is seen but notes an unrelated lung nodule. What should you do with this incidental finding, or “incidentaloma”?

Go to Top